Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model. 2008

Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
Institute of Neurobiology and Molecular Medicine, CNR, Via Fosso del Cavaliere 100, 00133 Rome, Italy. monica.rinaldi@artov.inmm.cnr.it

The idiotypic structure present on B-cell neoplasms is a tumor-specific antigen and an attractive target for immunotherapy. Here, the tumor protective effects recruited by CDR3-based DNA vaccines in the poorly immunogenic, highly aggressive 38C13 murine B-cell lymphoma model were evaluated. The regions belonging to the idiotypic V(H) and V(L) CDR3 sequences were chosen for the design of two synthetic mini-genes and arranged in high-level expression plasmids. Syngeneic C3H/HeN mice were immunized by intramuscular electroporation with pV(H)CDR3-IL-2 and pV(L)CDR3-IL-2 naked DNAs. This approach provided protection in about 60% of animals challenged with a 2-fold lethal dose of tumor cells, as opposed to non-survivors in control groups. Furthermore, a long-term survival was induced in these mice since they were still alive and tumor-free 4 months following tumor challenge. Analysis of the humoral immunity revealed the presence of antibodies reactive with the peptides encompassing the CDR3 sequences in the sera of vaccinated mice. Moreover, immune sera specifically reacted with the parental 38C13 tumor cells in flow cytometry assays, indicating that such immunization elicited anti-idiotypic antibodies. These findings provide a basis for exploring the use of CDR3-based DNA vaccines against B-cell lymphoma.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
February 1987, Journal of immunology (Baltimore, Md. : 1950),
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
January 1996, International journal of cancer,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
June 1997, Cancer research,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
July 2007, Journal of translational medicine,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
April 1999, Journal of immunology (Baltimore, Md. : 1950),
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
December 2014, Korean journal of urology,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
April 1981, Cancer research,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
October 2013, Journal of translational medicine,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
December 2015, Scientific reports,
Monica Rinaldi, and Daniela Fioretti, and Sandra Iurescia, and Emanuela Signori, and Pasquale Pierimarchi, and Davide Seripa, and Giancarlo Tonon, and Vito Michele Fazio
April 2007, Vaccine,
Copied contents to your clipboard!